008930.KS Hanmi Science Co., Ltd. Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
11:00
Aug 25
Biotech lacks continuity and sustained market leadership.
The pharmaceutical and biotech sector currently lacks continuity, as evidenced by Hanmi Pharm and Hanmi Science giving up massive gains almost immediately. The sector needs sustained leadership to build market excitement, making it a difficult area to trade right now.
008930.KS
MED
11:00
Aug 24
Massive obesity drug export deal boosts valuation.
Hanmi Pharm secured a massive 3.2 trillion won technology export deal with a Roche subsidiary for a novel obesity drug that preserves muscle mass. This landmark deal significantly boosts the fundamentals and investor sentiment for both Hanmi Pharm and its holding company, Hanmi Science.
HIGH

About 008930.KS Analyst Coverage

Buzzberg tracks 008930.KS (Hanmi Science Co., Ltd.) across 1 sources. 1 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (50%). 2 total trade ideas tracked. Past 7 days: 1 bullish, 1 watch. Latest voices: Park Hyun-sang, Lee Kwon-hee.